A new study confirmed the validity of a blood test that can diagnose patients with GLUT1 deficiency syndrome, a treatable neurometabolic disease that causes a wide range of neurologic symptoms in ...
None — 12-year-old Remi Savioz was diagnosed with a rare neuro-metabolic brain disease called Glucose Transporter 1, which affects the amount of glucose that reaches the brain. She is one of only 200 ...
GLUT1 expression in high-risk prostate cancer: Correlation with 18F-FDG-PET/CT and clinical outcome.
Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer. Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a ...
The cover for issue 57 of Oncotarget features figure 2, 'Overall survival analysis of GLUT1, PD-L1, and histologic architecture,' by Chamseddin, et al. The cover for issue 57 of Oncotarget features ...
Morning Overview on MSN
Study links high altitude to lower diabetes risk via sugar-hungry red cells
New research has identified a biological mechanism that may explain why people living at higher elevations tend to develop type 2 diabetes at lower rates. Under low-oxygen conditions typical of ...
Lung tumors are home to immune cells that affect their growth and resistance to treatment. Looking at neutrophils, scientists led by EPFL have discovered that the key might lie in the cells' ability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results